Opening book details…
About this Medicine article
Drug-drug interaction (DDI) assessments of ruxolitinib, a dual substrate of CYP3A4 and CYP2C9, using a verified physiologically based pharmacokinetic (PBPK) model to support regulatory submissions by Umehara, Kenichi; Huth, Felix; Jin, Yi; Schiller, Hilmar; Aslanis, Vassilios; Heimbach, Tycho; He, Handan is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Umehara, Kenichi; Huth, Felix; Jin, Yi; Schiller, Hilmar; Aslanis, Vassilios; Heimbach, Tycho; He, Handan
- Publisher
- Walter de Gruyter GmbH (ISSN 2363-8907)
- Published
- 2019
- Language
- EN
- Field
- Medicine (Health Sciences)